Publications by authors named "Andrew Preece"

Claim this Profile
A
A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.
Alison Moore, Andrew Preece, Raj Sharma, Liam G Heaney, Richard W Costello

Eur Respir J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial Setting.
Edward M Kerwin, Andrew Preece, Dimitra Brintziki, Kathryn A Collison, Raj Sharma

J Allergy Clin Immunol Pract· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD.
Job van der Palen, Wendy Moeskops-van Beurden, Carolyn M Dawson, Wai-Yee James, Andrew Preece

Int J Chron Obstruct Pulmon Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Clinical Trial Comparing the ELLIPTA and HandiHaler Dry Powder Inhalers in Patients With COPD: Inhaler-Specific Attributes and Overall Patient Preference.
Kathryn A Collison, Pinal Patel, Andrew F Preece, Richard H Stanford, Raj K Sharma

COPD· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
David Prime, Wilfried de Backer, Melanie Hamilton, Anthony Cahn, Andrew Preece

J Aerosol Med Pulm Drug Deliv· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized study.
Rashmi Mehta, Kelly Hardes, Noushin Brealey, Lee Tombs, Andrew Preece

Int J Chron Obstruct Pulmon Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
Dennis Kelleher, Lee Tombs, Andrew Preece, Noushin Brealey, Rashmi Mehta

Pulm Pharmacol Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of moderate hepatic impairment on the pharmacokinetic properties and tolerability of umeclidinium and vilanterol in inhalational umeclidinium monotherapy and umeclidinium/vilanterol combination therapy: an open-label, nonrandomized study.
Rashmi Mehta, Kelly Hardes, Dennis Kelleher, Andrew Preece, Lee Tombs

Clin Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacokinetics and pharmacodynamics of inhaled once-daily umeclidinium in healthy adults deficient in CYP2D6 activity: a double-blind, randomized clinical trial.
Anthony Cahn, Rashmi Mehta, Andrew Preece, James Blowers, Alison Donald

Clin Drug Investig· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat inhaled doses of umeclidinium in healthy subjects: two randomized studies.
Anthony Cahn, Ruth Tal-Singer, Isabelle J Pouliquen, Rashmi Mehta, Andrew Preece

Clin Drug Investig· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial.
Dennis L Kelleher, Rashmi S Mehta, Bernadette M Jean-Francois, Andrew F Preece, James Blowers

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study.
Rashmi Mehta, Dennis Kelleher, Andrew Preece, Stephen Hughes, Glenn Crater

Int J Chron Obstruct Pulmon Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial assessment of single and repeat doses of inhaled umeclidinium in patients with chronic obstructive pulmonary disease: two randomised studies.
Ruth Tal-Singer, Anthony Cahn, Rashmi Mehta, Andrew Preece, Glenn Crater

Eur J Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus recognition by specific natural antibodies and complement results in MHC I cross-presentation.
Antoine Dürrbach, Emma Baple, Andrew F Preece, Bernard Charpentier, Kenth Gustafsson

Eur J Immunol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement.
Andrew F Preece, Karen M Strahan, James Devitt, Fumi-ichiro Yamamoto, Kenth Gustafsson

Blood· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis